{"id": "1356606141451493376", "creation": 1612275083.0, "user_id": "1100685738", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "JUST IN:\n\nInterim analysis of Russian #COVID19 #vaccine phase 3 trial involving nearly 20,000 participants suggests a two-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. \n\nNo serious adverse events were deemed to be associated with vaccination. \n\n{THE LANCET}", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#COVID19"]}